Naziv |
Akcije |
Murgić, Jure; Jazvić, Marijana; Miletić, Marija; Prgomet Sečan, Angela; Ulamec, Monika; Vilović, Katarina; Pezelj, Ivan; Tomašković, Igor; Bokarica, Pero; Saratlija Novaković, Žana et al.
Pathological downstaging, disease control and survival after neoadjuvant chemotherapy for bladder cancer in Croatia; a real-world study // Libri oncologici : Croatian journal of oncology, 51, 1. 2023. str. 73-74 |
|
Brčić, Hrvoje; Lekić, Mirela; Jazvić, Marijana; Murgić, Jure; Miletić, Marija; Prgomet Sečan, Angela; Tomašković, Igor; Hrkać, Adelina; Bokarica, Pero; Kaučić, Hrvoje et al.
Stereotactic body radiation therapy in patients with advanced urothelial cancer treated with immunotherapy: early experience within croatian oncology referral network // Libri oncologici : Croatian journal of oncology, 51, 1. 2023. str. 83-84 |
|
Miletić, Marija; Brčić, Hrvoje; Prgomet Sečan, Angela; Franceschi, Dora; Šambić Penc, Mirela; Boraska Jelavić, Tihana; Murgić, Jure; Jazvić, Marijana; Komić, Dubravka; Omrčen,Tomislav et al.
Dynamics of neutrophil-to-lymphocyte ratio as a biomarker of clinical response to immune checkpoint inhibitor therapy in a multicenter cohort of patients with advanced urothelial cancer within Croatian genitourinary cancer network // Libri oncologici : Croatian journal of oncology, 51, 1. 2023. str. 64-65 |
|
Prejac, Juraj; Omrčen, Tomislav; Radić, Jasna; Vrdoljak, Eduard; Frobe, Ana; Pleština, Stjepko
Predicting Trifluridine/Tipiracil Treatment in Refractory Metastatic Colorectal Cancer Patients: A Multicenter Exploratory Analysis // Oncology, (2023), doi: 10.1159/000533567 |
|
Omrčen, Tomislav; Boraska Jelavić, Tihana; Komić, Dubravka
Atezolizumab in patients with metastatic urothelial cancer - retrospective analysis of the treatment experience at the Department of Oncology and Radiotherapy, University Hospital of Split. // Libri oncologici : Croatian journal of oncology, 51, Supplement 1. 2023. str. 53-54 |
|
KATIĆ, ANDRIJA ; Omrčen, Tomislav ; Viculin, Jelena ; Boban, Marijo ; Hrepić, Darijo ; Vrdoljak, Eduard
TREATMENT PATTERNS AND SURVIVAL OUTCOMES OF PATIENTS WITH METASTATIC GASTRIC CANCER AT THE DEPARTMENT OF ONCOLOGY AND RADIOTHERAPY, UNIVERSITY HOSPITAL OF SPLIT FROM 2018 TO 2020 - A RETROSPECTIVE ANALYSIS. // Libri oncologici : Croatian journal of oncology, 50, 1. 2022. str. 154-156 |
|
Omrčen, Tomislav
SYSTEMIC TRIPLE THERAPY IN METASTATIC HORMONE SENSITIVE PROSTATE CANCER (MHSPC) // Acta clinica Croatica, 61 (2022), Supplement 3; 81-85. doi: 10.20471/acc.2022.61.s3.12 |
|
Prejac, Juraj ; Omrčen, Tomislav ; Radić, Jasna ; Vrdoljak, Eduard ; Fröbe, Ana ; Pleština, Stjepko
A multicenter exploratory analysis of the possible predictive factors for trifluridine/tipiracil in refractory metastatic colorectal cancer // Annals of oncology / André, F. (ur.). 2022. str. S316-S316 doi: 10.1016/j.annonc.2022.04.276 |
|
Jović Zlatović, J. ; Bevanda, M. ; Skelin, M. ; Telesmanić Dobrić, V. ; Curić, Z. ; Marijanović, I. ; Grubisić-Čabo, F. ; Krečak, I. ; Tomić, S. ; Kralik, K. et al.
P-206 Association between primary tumor site of colorectal cancer and RAS/BRAF mutational status with venous thromboembolism: A retrospective- prospective cohort study from 3 Croatian oncology centers // Annals of oncology. 2022. str. S322-S323 doi: 10.1016/j.annonc.2022.04.296 |
|
Omrčen Tomislav
Non-hormonal systemic treatment of prostate cancer // Libri oncologici : Croatian journal of oncology. 2021. str. 80-80 |
|